Literature DB >> 15591109

Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori.

Motohiro Kobayashi1, Junya Mitoma, Naoshi Nakamura, Tsutomu Katsuyama, Jun Nakayama, Minoru Fukuda.   

Abstract

Helicobacter pylori infects over half the world's population and is a leading cause of peptic ulcer and gastric cancer. H. pylori infection results in chronic inflammation of the gastric mucosa, and progression of chronic inflammation leads to glandular atrophy and intestinal metaplasia. However, how this chronic inflammation is induced or maintained is not well known. Here, we show that chronic inflammation caused by H. pylori infection is highly correlated with de novo synthesis of peripheral lymph node addressin (PNAd) presented on high-endothelial venule (HEV)-like vessels. The number of HEV-like vessels dramatically increases as chronic inflammation progresses. We found that the PNAd is bound by L-selectin.IgM chimeric protein, and decorated by NCC-ST-439 antibody, which is suggested to recognize both nonsulfated and 6-sulfated sialyl Lewis X on core 2 branched O-glycans, and MECA-79 antibody, which reacts with 6-sulfo N-acetyllactosamine on extended core 1 O-glycans. These results indicate that PNAd on HEV-like vessels present in the gastric mucosa subsequent to H. pylori infection is similar to those on HEVs present in the secondary lymphoid organs, which are essential for lymphocyte circulation. Moreover, eradication of H. pylori is associated with the disappearance of HEV-like vessels in the gastric mucosa. By contrast, very few PNAd were found in the gastric mucosa of patients with chemical gastritis caused by nonsteroidal antiinflammatory drugs. These results strongly suggest that PNAd in HEV-like vessels plays a critical role in lymphocyte recruitment during chronic inflammation induced by H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591109      PMCID: PMC539746          DOI: 10.1073/pnas.0407503101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  The Cdx-1 and Cdx-2 homeobox genes in the intestine.

Authors:  J N Freund; C Domon-Dell; M Kedinger; I Duluc
Journal:  Biochem Cell Biol       Date:  1998       Impact factor: 3.626

Review 2.  T-cell function and migration. Two sides of the same coin.

Authors:  U H von Andrian; C R Mackay
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

3.  Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase.

Authors:  J C Yeh; N Hiraoka; B Petryniak; J Nakayama; L G Ellies; D Rabuka; O Hindsgaul; J D Marth; J B Lowe; M Fukuda
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

4.  Sulfated sialyl Lewis X, the putative L-selectin ligand, detected on endothelial cells of high endothelial venules by a distinct set of anti-sialyl Lewis X antibodies.

Authors:  C Mitsuoka; N Kawakami-Kimura; M Kasugai-Sawada; N Hiraiwa; K Toda; H Ishida; M Kiso; A Hasegawa; R Kannagi
Journal:  Biochem Biophys Res Commun       Date:  1997-01-23       Impact factor: 3.575

5.  A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34.

Authors:  N Hiraoka; B Petryniak; J Nakayama; S Tsuboi; M Suzuki; J C Yeh; D Izawa; T Tanaka; M Miyasaka; J B Lowe; M Fukuda
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

6.  BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma.

Authors:  L Mazzucchelli; A Blaser; A Kappeler; P Schärli; J A Laissue; M Baggiolini; M Uguccioni
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue.

Authors:  A Dogan; M Du; A Koulis; M J Briskin; P G Isaacson
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

8.  Endothelial L-selectin ligands are likely to recruit lymphocytes into rejecting human heart transplants.

Authors:  S Toppila; T Paavonen; M S Nieminen; P Häyry; R Renkonen
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

9.  Specific detection of sialyl Lewis X determinant carried on the mucin GlcNAcbeta1-->6GalNAcalpha core structure as a tumor-associated antigen.

Authors:  K Kumamoto; C Mitsuoka; M Izawa; N Kimura; N Otsubo; H Ishida; M Kiso; T Yamada; S Hirohashi; R Kannagi
Journal:  Biochem Biophys Res Commun       Date:  1998-06-18       Impact factor: 3.575

10.  Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases.

Authors:  M Salmi; K Granfors; R MacDermott; S Jalkanen
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

View more
  42 in total

1.  Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing.

Authors:  Jotaro Hirakawa; Koichiro Tsuboi; Kaori Sato; Motohiro Kobayashi; Sota Watanabe; Atsushi Takakura; Yasuyuki Imai; Yuki Ito; Minoru Fukuda; Hiroto Kawashima
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

2.  Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase.

Authors:  Carl-Fredrik Flach; Anna Karin Östberg; Anne-Therese Nilsson; Rene De Waal Malefyt; Sukanya Raghavan
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa.

Authors:  Anna Lundgren; Christina Trollmo; Anders Edebo; Ann-Mari Svennerholm; B Samuel Lundin
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases.

Authors:  Motohiro Kobayashi; Hitomi Hoshino; Kenichi Suzawa; Yasuhiro Sakai; Jun Nakayama; Minoru Fukuda
Journal:  Semin Immunopathol       Date:  2012-05-10       Impact factor: 9.623

5.  An integrin alpha4beta7•IgG heterodimeric chimera binds to MAdCAM-1 on high endothelial venules in gut-associated lymphoid tissue.

Authors:  Hitomi Hoshino; Motohiro Kobayashi; Junya Mitoma; Yoshiko Sato; Minoru Fukuda; Jun Nakayama
Journal:  J Histochem Cytochem       Date:  2011-03-23       Impact factor: 2.479

6.  Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer.

Authors:  Hisashi Shimojo; Motohiro Kobayashi; Takayuki Kamigaito; Yasuyo Shimojo; Minoru Fukuda; Jun Nakayama
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

7.  Atomic force microscopy measurements reveal multiple bonds between Helicobacter pylori blood group antigen binding adhesin and Lewis b ligand.

Authors:  P Parreira; Q Shi; A Magalhaes; C A Reis; J Bugaytsova; T Borén; D Leckband; M C L Martins
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

8.  TNFΔARE Mice Display Abnormal Lymphatics and Develop Tertiary Lymphoid Organs in the Mesentery.

Authors:  Sonia Rehal; Pierre-Yves von der Weid
Journal:  Am J Pathol       Date:  2017-02-06       Impact factor: 4.307

9.  Alpha1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol alpha-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth.

Authors:  Heeseob Lee; Ping Wang; Hitomi Hoshino; Yuki Ito; Motohiro Kobayashi; Jun Nakayama; Peter H Seeberger; Minoru Fukuda
Journal:  Glycobiology       Date:  2008-05-05       Impact factor: 4.313

Review 10.  Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.